Clinical Trials

Carcinoma, Non-Small-Cell Lung

NCT01130519 2025-02-21

A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer

83 enrolled 17 charts

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell, Kidney Neoplasms

NCT01306045 2024-10-01

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

647 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

NCT02961374 2022-07-26

Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer

46 enrolled 13 charts

Attenuated familial adenomatous polyposis, Adenomatous Polyposis Coli

NCT01222689 2020-07-31

Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

46 enrolled 13 charts

Pancreatic Neoplasms

NCT02169284 2020-07-07

Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery

50 enrolled 27 charts

Urinary Bladder Neoplasms

NCT00126581 2019-08-07

Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer

188 enrolled 16 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Pleural Effusion, Malignant

NCT01822496 2019-08-05

Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

59 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT01866410 2019-05-16

Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

37 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT01688973 2019-01-03

Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery

55 enrolled 16 charts

Carcinoma, Renal Cell

NCT00054132 2017-07-24

Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer

38 enrolled 10 charts

Breast

Breast Neoplasms

NCT01229150 2017-05-23

Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva...

89 enrolled 28 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01294306 2016-11-29

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

80 enrolled 10 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00445588 2016-04-27

Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

56 enrolled 6 charts

CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00059787 2015-12-01

Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma

56 enrolled 10 charts

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms

NCT00365391 2015-07-09

Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer

27 enrolled 8 charts

Carcinoma, Hepatocellular

NCT01093222 2015-06-30

Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma

40 enrolled 16 charts

Bile Duct Neoplasms, Gallbladder Neoplasms, Klatskin Tumor

NCT00032110 2015-04-15

Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

30 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT00754494 2015-01-06

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma

45 enrolled 18 charts

Colonic Neoplasms, Rectal Neoplasms, Adenomatous Polyps

NCT00482625 2014-10-16

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

6 enrolled 8 charts

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT00976677 2014-05-30

Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer

10 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung

NCT00356889 2014-05-28

Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors

56 enrolled 9 charts

Bile Duct Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms

NCT00091026 2014-05-15

Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer

143 enrolled 9 charts

Pancreatic Neoplasms

NCT00126542 2014-05-14

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

35 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00030485 2014-01-27

Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer

Endometrial Neoplasms

NCT00054496 2014-01-10

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Phase 2 Unknown

73 enrolled

CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00278187 2013-12-19

Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00039494 2013-08-02

Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors

171 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00032123 2013-06-24

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00030537 2013-06-19

Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00062101 2013-06-06

Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00087269 2013-06-06

Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection

110 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00033462 2013-06-04

Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer

78 enrolled

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular

NCT00045526 2013-06-04

Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

48 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00060307 2013-02-28

Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer

40 enrolled

Carcinoma, Renal Cell

NCT00087412 2013-02-28

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer

65 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT00039182 2013-01-24

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Other solid neoplasmThoracic

55 enrolled

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00047333 2013-01-23

Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed

80 enrolled

Carcinoma, Hepatocellular

NCT00031993 2013-01-17

Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix

51 enrolled

Uterine Cervical Neoplasms

NCT00801385 2009-08-25

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Phase 2 Unknown

47 enrolled